Comparison of desoximetasone and hydrocortisone butyrate in psoriasis.

MedLine Citation:

PMID:
60029
Owner:
NLM
Status:
MEDLINE

Abstract/OtherAbstract:

Thirty psoriatics were treated for 2 weeks on a double-blind controlled basis with desoximetasone (0.25%) and with hydrocortisone butyrate (0.1%). It was a randomised left-right comparative trial. Thirteen out of 27 patients preferred desoximetasone, 3 patients preferred hydrocortisone butyrate. There was also a significantly better effect of desoximetasone as judged by the observer after the second week of treatment.